Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chromosomal aberrations in iris melanomas.
Mensink HW, Vaarwater J, de Keizer RJ, de Wolff-Rouendaal D, Mooy CM, de Klein A, Paridaens D. Mensink HW, et al. Br J Ophthalmol. 2011 Mar;95(3):424-8. doi: 10.1136/bjo.2010.181289. Epub 2010 Sep 29. Br J Ophthalmol. 2011. PMID: 20881029
Chromosome 3 intratumor heterogeneity in uveal melanoma.
Mensink HW, Vaarwater J, Kiliç E, Naus NC, Mooy N, Luyten G, Brüggenwirth HT, Paridaens D, de Klein A. Mensink HW, et al. Invest Ophthalmol Vis Sci. 2009 Feb;50(2):500-4. doi: 10.1167/iovs.08-2279. Epub 2008 Sep 29. Invest Ophthalmol Vis Sci. 2009. PMID: 18824727
Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W, Lodder EM, Mensink HW, Kiliç E, Naus NC, Brüggenwirth HT, van Ijcken W, Paridaens D, Luyten GP, de Klein A. van Gils W, et al. Among authors: mensink hw. Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4254-62. doi: 10.1167/iovs.08-2033. Epub 2008 Jun 14. Invest Ophthalmol Vis Sci. 2008. PMID: 18552379
Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
Vaarwater J, van den Bosch T, Mensink HW, van Kempen C, Verdijk RM, Naus NC, Paridaens D, Brüggenwirth HT, Kiliç E, de Klein A. Vaarwater J, et al. Among authors: mensink hw. Melanoma Res. 2012 Feb;22(1):30-7. doi: 10.1097/CMR.0b013e32834e6a67. Melanoma Res. 2012. PMID: 22157614
Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
Yavuzyigitoglu S, Mensink HW, Smit KN, Vaarwater J, Verdijk RM, Beverloo B, Brüggenwirth HT, van Marion R, Dubbink HJ, Paridaens D, Naus NC, de Klein A, Kiliç E; Rotterdam Ocular Melanoma Study Group (ROMS). Yavuzyigitoglu S, et al. Among authors: mensink hw. Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2232-9. doi: 10.1167/iovs.15-18608. Invest Ophthalmol Vis Sci. 2016. PMID: 27116551
Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.
Bol KF, van den Bosch T, Schreibelt G, Mensink HW, Keunen JE, Kiliç E, Japing WJ, Geul KW, Westdorp H, Boudewijns S, Croockewit SA, van Rossum MM, de Goede AL, Naus NC, van der Graaf WT, Gerritsen WR, de Klein A, Punt CJ, Figdor CG, Cohen VM, Paridaens D, de Vries IJ. Bol KF, et al. Among authors: mensink hw. Ophthalmology. 2016 Oct;123(10):2265-7. doi: 10.1016/j.ophtha.2016.06.027. Epub 2016 Jul 29. Ophthalmology. 2016. PMID: 27476772 Clinical Trial. No abstract available.
19 results